Clinical Observation
Dysglycemia is a common and independent risk factor for poor prognosis in critically ill patients. [1] Little research on blood glucose (BG) management has been done in Intensive Care Units (ICUs) in China. Understanding current practice patterns, as well as concerns and beliefs surrounding BG control in critically ill patients, is essential for further research on this issue and future medical education in intensive care physicians. Therefore, we designed and conducted this survey of intensive care physicians' attitudes, knowledge, and practices concerning the treatment and prevention of dysglycemia, including hyperglycemia, hypoglycemia, and/or marked BG variability.
This survey was conducted with the approval of the Institutional Review Board of the Affiliated Hospital of Guizhou Medical University, China. The questionnaire was developed based on clinical practices and related articles [2, 3] and was validated by a panel of intensivists. The first questionnaire survey was conducted between May 2013 and January 2014 in Guizhou Province and Hangzhou city, Zhejiang Province. The second questionnaire survey was conducted in October 2016 in five different districts (Zhejiang Province, Guizhou Province, Hainan Province, Fujian Province, and Chongqing city). The surveys were distributed to ICU practitioners by field handout, regular mail, or email. We informed the physicians by telephone or WeChat and obtained their consent before the questionnaires were sent via mail or email. We collected the questionnaires 3-4 weeks later.
The results of the questionnaire surveys were summarized and reported using frequency analysis (shown as frequency and percentage). In cases of categorical variables, data were expressed in numbers and percentages, and differences were tested using Fisher's exact test. A two-tailed P < 0.05 was considered statistically significant. Statistical analysis was performed using SPSS 20.0 for Windows (IBM SPSS Statistics version 20, USA).
A total of 192 physicians from 57 ICUs (57 hospitals) and 37 physicians from 13 ICUs (12 hospitals) responded to the first and the second questionnaires, respectively. In the first survey, 14 (25%), 7 (12%), 35 (61%), and 1 (2%) were upper first-class hospitals, middle first-class hospitals, upper second-class hospitals, and a middle second-class hospital, respectively. Overall, 50/57 (88%) mixed ICUs participated in the first survey, and 10/13 (77%) mixed ICUs participated in the second survey; 9/55 (16%), and 73/123 (59%) of the respondents had worked in the ICU for 5 years or more in Guizhou Province and Hangzhou city, respectively (P < 0.001). Details of the study demographics are presented in Supplementary Table 1. To the best of our knowledge, this was the first study to describe attitudes, knowledge, and practices regarding BG control in ICUs in China. We found that the methods of infusing glucose and treating hyperglycemia are still controversial, although guidelines for the management of dysglycemia in critically ill patients were published in 2012. [2] These surveys highlight the gap between what intensive care physicians perceive and what is found in the articles. The definitions of hyperglycemia and hypoglycemia and the ranges of glucose targets vary widely. The results of the surveys showed that most practitioners routinely started to use insulin when BG exceeded 11.1 mmol/L or even higher; however, the guidelines suggest that BG ≥8.3 mmol/L triggers the initiation of insulin therapy for most critically ill patients. [2] In addition, more than half of the respondents defined hypoglycemia as a BG level of <3.0 mmol/L, although BG ≤3.9 mmol/L was associated with increased hospital mortality in critically ill patients. [4] Most of the respondents generally administered 40 ml 50% dextrose to treat hypoglycemia; however, few respondents remeasured BG levels in 15 min, therefore the risk of iatrogenic hyperglycemia may increase. [2] BG variability is associated with mortality in critically ill patients. [1] This study also showed that 142/188 (76%) and 34/37 (92%) of respondents paid attention to suppressing the BG variability in the first survey and the second survey, respectively. However, in the majority of ICUs and respondents, the timing of BG measurement was unclear, and the BG values were often measured according to a fixed interval (that is, every 4 h). The guidelines suggest that BG should be monitored every 1-2 h for most patients receiving insulin infusion. [2] In addition, <10% of the respondents used insulin according to local strategies in our survey, which may reflect the fact that most ICUs did not develop local strategies for BG management.
The present study has some limitations. The first survey was conducted more than 3 years ago; however, the second survey was conducted in 2016 and showed that most results were similar to those in the first survey. Another limitation was that the sample was small and most respondents worked in Guizhou Province and Hangzhou city, Zhejiang Province. The study may not represent national intensivists' attitudes and practice patterns regarding BG control. A large-scale national survey is needed.
In summary, more education is needed for BG control in intensive care physicians. Furthermore, persistent variation in practice also suggests a need for more clinical trials of BG control in critically ill patients.
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